NCM·Healthcare·$55M·#252 / 520 in Healthcare
BDMD Baird Medical Investment Holdin
44SPECULATIVE
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY17
VALUATION93
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-39.2%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
83.8%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
2 months
3
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
61.5%
45
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.4x
93
< 3x strong
Rule of 40
Growth rate plus operating margin
-152
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
62.8%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-13.9%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE BDMD WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when BDMD's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.